跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SPIRULINA TABLET 300MG - NPRA Drug Approval Details
Approvals
/
NPRA
/
SPIRULINA TABLET 300MG
Approved
STANDARD
SPIRULINA TABLET 300MG
PRIME PHARMACEUTICAL SDN. BHD.
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Nov 28, 2025
Approval ID
431a28c171313744
Company
PRIME PHARMACEUTICAL SDN. BHD.
Type
Standard
Approval Details
Approval Id
431a28c171313744
Drug Approval Npra Name
SPIRULINA TABLET 300MG
Product Name
SPIRULINA TABLET 300MG
Registration Number
MAL20000424T
Holder Company Name
PRIME PHARMACEUTICAL SDN. BHD.
Holder Address
1505, LORONG PERUSAHAAN UTAMA 1 TAMAN PERINDUSTRIAN BUKIT TENGAH 14000 BUKIT MERTAJAM MALAYSIA
Holder Phone
04-5074787
Manufacturer Company Name
PRIME PHARMACEUTICAL SDN. BHD.
Manufacturer Address
1505, LORONG PERUSAHAAN UTAMA 1 TAMAN PERINDUSTRIAN BUKIT TENGAH 14000 BUKIT MERTAJAM MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL20000424T
Version
1751614223
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Nov 28, 2025
Approval ID
431a28c171313744
Type
Standard
Source
Official Source
Back to NPRA Approvals